Helios Klinikum Berlin-Buch GmbH — Clinical Trial Site

113 Registered trials

53 Currently recruiting

Organisation

Helios Klinikum Berlin-Buch GmbH

Location

Berlin, Germany

Identifier

ORG-100025249

Address

Schwanebecker Chaussee 50, Buch, 13125, Germany

Departments

#3123: Geburtshilfe und Gynäkologie
#40369: Clinic for Paediatrics and Adolescent Medicine
049015: Brustzentrum
1406: Onco-Hematology
Abteilung Hämatologie und Stamzelltransplantation
Brustzentrum
Brustzentrum und gynaekologisches Zentrum
Clinic for Gynecology and Obstetrics
Clinic for Hematology and Stem Cell Transplantation
Clinic for Oncology and Palliative Medicine
Department for Oncology and Palliative Care / Sarkomzentrum
Department of Oncology and Palliative Medicine
Frauenklinik
Frauenklinik, Studiensekretariat, Brustzentrum, B2
Frauenklinik/ Brustzentrum
Geburtshilfe und Gynaekologie
Geburtshilfe und Gynäkologie
Gynacology (Klinik für Gynäkologie und Geburtshilfe)
Gynaecology Department
Gynäkologie
Gynäkologie und Geburtshilfe
Gynecological Oncology
Gynecology and Obstetrics
Haematologie, Onkologie, Tumorimmunologie
Hämatologie und Stammzelltransplantation
Hämatologie und Zelltherapie
Hämatologie, Onkologie und Tumorimmunologie
Hämatologie/ Onkologie
Hamatologie/Onkiologie
HELIOS Klinikum Berlin-Buch Klinik für Gynäkologie und Geburtshilfe
Hemato-Oncology
Hematology and stem cell transplantation
Kardiologie
Kinder- und Jugendmedizin
Kinderklinik Pädiatrische Hämatologie und Onkologie
Klinik fuer Gynaekologie und Geburtshilfe
Klinik Fuer Haematologie Onkologie Und Turmorimmunologie
Klinik fuer Kinder und Jugendmedizin
Klinik für Geburtshilfe und Gynäkologie
Klinik für Gynäkologie und Geburtshilfe
Klinik für Hämatologie und Stammzelltherapie
Klinik für Hämatologie und Stammzelltransplantation
Klinik für Hämatologie und SZT
Klinik für Hämatologie und Zelltherapie
Klinik für Hämatologie, Onkologie und Immunologie
Klinik für Kinder- und Jugendmedizin
Klinik für Kinder- und Jugendmedizin Fachambulanz Kinderrheumatologie
Klinik für Kinder- und Jugendmedizin Päd. Onkologie/Hämatologie
Klinik für Kinder- und Jugendmedizin, Päd. Onkologie/Hämatologie
Klinik für Onkologie und Palliativmedizin
Klinik für Plastische und Ästhetische Chirurgie
Klinikum für Hämatologie und Stammzelltransplantation
N/A
Obstetrics and Gynecology
Oncology
Oncology Centre Berlin-Buch
Oncology for pediatrics
Onkologie
Onkologie und Palliativmedizin
Pädiatrische Hämatologie und Onkologie
Pädiatrische Onkologie/Hämatologie
Pediatric and adolescent medicine
Pediatric Hematology/Oncology
Sarkomzentrum Berlin-Brandenburg
Zentrum Hämatologie, Onkologie, Palliativmedizin

Clinical trials at this site (113)

Search interface

International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Ante… Recruiting

2023-505811-18-00 Uveitis 5 2019-11-11
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JUVE-X) Recruiting

2023-506131-15-00 Juvenile Idiopathic Arthritis 5 2019-09-10
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells. Recruiting

2023-504201-36-00 Defined by parent protocol. The study will enroll all a 10 2018-12-21
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA) Recruiting

2024-512701-11-00 Systemic Juvenile Idiopathic Arthritis (sJIA) 4 2018-08-29
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
A Study to Test Inavolisib Treatments in Patients with Early-Stage, PIK3CA-Mutated Breast Cancer Ended

2024-518811-20-00 Early-Stage, PIK3CA-Mutated Breast Cancer (BC) 4 2025-09-30
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Gastroesophageal Junction Adenocarcinoma 5 2025-07-31
A trial to learn more about the effects of ribociclib taken with endocrine therapy in patients with early breast cancer. Ended

2022-503001-38-01 HR-positive HER-2- negative Breast Cancer 5 2025-07-08
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab Injections Before and After Surgery for the Treatment of Adult Patients wit… Ended

2023-505928-59-00 Triple Negative or Hormone Receptor low/HER2-negative B 5 2024-04-15
A Phase 3 Study of DB-1303 vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer Ended

2023-507333-17-00 HER2-low, Hormone Receptor Positive, Metastatic Breast 5 2024-04-15
Phase 3 study of belzutifan plus pembrolizumab as adjuvant treatment in renal cell carcinoma (RCC) Ended

2023-505023-31-00 Renal cell carcinoma 5 2023-11-17
(Peak) A Clinical Study of CGT9486+Sunitinib vs Sunitinib in Patients with Gastrointestinal Stromal Tumors Ended

2022-500637-80-00 gastrointestinal stromal tumor 5 2023-03-28
A prospective multicenter phase 2 study of the chemotherapy-light combination of intravenous rituximab with the antibody-drug conjugate pol… Ended

2024-513949-37-00 previously untreated aggressive B-cell lymphoma 4 2023-03-16
A FIRST-IN-HUMAN (FIH) STUDY OF IDRX-42 IN PARTICIPANTS WITH METASTATIC AND/OR UNRESECTABLE GASTROINTESTINAL STROMAL TUMORS (GIST) Ended

2024-514930-19-00 metastatic and/or unresectable gastrointestinal stromal 9 2022-10-07
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable… Ended

2023-504195-14-00 PD-L1-negative metastatic triple-negative breast cancer 5 2022-08-31
A Phase 2 study of INBRX-109 in adults with a type of unresectable or metastasized cancer of the bones and joints (Conventional Chondrosarco… Ended

2024-517528-20-00 Unresectable or metastatic conventional chondrosarcoma 4 2022-04-19
This is a multicenter, randomized, Phase 3 study with vimseltinib or placebo in patients with Tenosynovial Giant Cell Tumor, consisting of 2… Ended

2024-513624-42-00 Tenosynovial Giant Cell Tumor 5 2021-12-16
DALY 2-EU Ended

2023-506270-13-00 Relapsed/refractory diffuse large B cell lymphoma (R-R 4 2021-07-27
Phase Ib/III Study of Capivasertib + CDK4/6 Inhibitors + Fulvestrant as Treatment for Advanced/Metastatic HR+/HER2-Breast Cancer (CAPItello-… Ended

2023-504997-39-00 Hormone Receptor-Positive and Human Epidermal Growth Fa 5 2021-06-14
A Randomised, Double-Blind, Phase III Study of AZD9833 plus Palbociclib versus Anastrozole plus Palbociclib in Patients with ER-Positive HER… Ended

2023-503995-26-00 Estrogen Receptor-Positive, HER2-Negative Advanced Brea 5 2021-05-11
Clinical trial comparing Trastuzumab Deruxtecan with Trastuzumab Emtansine in high-risk HER2-positive patients with residual breast cancer f… Ended

2023-507961-24-00 High-Risk HER2-Positive Breast Cancer 5 2021-04-19